MEDA PHARMS FDA Approval NDA 019919

NDA 019919

MEDA PHARMS

FDA Drug Application

Application #019919

Documents

Review1997-08-08

Application Sponsors

NDA 019919MEDA PHARMS

Marketing Status

Discontinued001

Application Products

001SUPPOSITORY;RECTAL500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1ROWASAMESALAMINE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1990-12-18STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1997-08-08STANDARD
LABELING; LabelingSUPPL4AP2001-10-01STANDARD

Submissions Property Types

ORIG1Null0
SUPPL2Null0
SUPPL4Null0

CDER Filings

MEDA PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 19919
            [companyName] => MEDA PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"ROWASA","activeIngredients":"MESALAMINE","strength":"500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","dosageForm":"SUPPOSITORY;RECTAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"Yes"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"ROWASA","submission":"MESALAMINE","actionType":"500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","submissionClassification":"SUPPOSITORY;RECTAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.